Clinical Trial Update: EBA, Safety and Tolerability of Sanfetrinem Cilexetil [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and tolerability of Sanfetrinem Cilexetil in pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Sanfetrinem Cilexetil (sanfetrinem cilexetil)

Snippet

Sponsor: TASK Applied Science | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: COMPLETED